Effects of MIP-1 alpha, MIP-3 alpha, and MIP-3 beta on the induction of HIV Gag-specific immune response with DNA vaccines.
about
In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells.Increased generation of HIV-1 gp120-reactive CD8+ T cells by a DNA vaccine construct encoding the chemokine CCL3.Targeting the tumor microenvironment to enhance antitumor immune responsesTechnologies for enhanced efficacy of DNA vaccines.Effect of Mucosal Cytokine Administration on Selective Expansion of Vaginal Dendritic Cells to Support Nanoparticle Transport.PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccinesStatistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults.Macrophage Inflammatory Protein-3 Alpha (MIP-3α)/CCL20 in HIV-1-Infected Individuals.Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model.Engineering immunity in the mucosal niche against sexually transmitted infections.CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model.Lactobacillus plantarum displaying CCL3 chemokine in fusion with HIV-1 Gag derived antigen causes increased recruitment of T cells.Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20 (CCL20) gene as immunoadjuvant.Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3.Co-administration of antigen with chemokine MCP-3 or MDC/CCL22 enhances DNA vaccine potency.Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.
P2860
Q33635879-3B4E7196-C449-48E6-8F82-C808E1D1C272Q34046807-BAA6BF78-617D-47B5-8DF0-0B9CC4FCDC53Q35176307-20237002-0F7A-4243-A8C8-AF7924705518Q35802958-D3360039-1D8D-4428-8FD1-581F35CD4F68Q36143091-522780AF-7100-4919-8F30-351C6D535016Q36220691-477E627D-33B2-4685-90C0-C96115EA3ACAQ36227366-8C166F74-3BD5-4B23-BDB9-2EA29EB27A17Q37241383-59E25D5F-929D-45F5-960B-B16283F10BA2Q37276912-1D8CF526-18E0-4862-96CA-89C63DA3881CQ37516937-97229D25-691C-4F0C-AF86-806C23176BA1Q38543768-3048FD76-D9E2-4CAA-B36C-E2D441483716Q38779935-D1EE37E2-E568-4184-B18E-04DAA6B6AEA5Q38825666-D745D7C7-995A-4BE4-BB06-5438FF804B8EQ42208607-8B5FB7FA-F67D-4382-8742-BBE309FB762AQ47719808-1756C731-8924-4FCD-9F8A-F38882780BF5Q50979846-34D7A02D-EC37-4677-BB54-A02A2A4D22B2Q55432126-E1F77DB4-C7E1-4135-B397-74B0C3BA7AF4
P2860
Effects of MIP-1 alpha, MIP-3 alpha, and MIP-3 beta on the induction of HIV Gag-specific immune response with DNA vaccines.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effects of MIP-1 alpha, MIP-3 ...... ne response with DNA vaccines.
@ast
Effects of MIP-1 alpha, MIP-3 ...... ne response with DNA vaccines.
@en
type
label
Effects of MIP-1 alpha, MIP-3 ...... ne response with DNA vaccines.
@ast
Effects of MIP-1 alpha, MIP-3 ...... ne response with DNA vaccines.
@en
prefLabel
Effects of MIP-1 alpha, MIP-3 ...... ne response with DNA vaccines.
@ast
Effects of MIP-1 alpha, MIP-3 ...... ne response with DNA vaccines.
@en
P2093
P2860
P356
P1433
P1476
Effects of MIP-1 alpha, MIP-3 ...... ne response with DNA vaccines.
@en
P2093
Kam W Leong
Ruijiang Song
Shuqin Liu
P2860
P304
P356
10.1038/MT.SJ.6300129
P577
2007-03-13T00:00:00Z